Stockwinners Market Radar for November 16, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:20 EST Cathie Wood's ARK Investment bought 226K shares of PagSeguro Digital on Tuesday

18:59 EST M&T Bank raises quarterly dividend 9% to $1.20 per share - M&T Bank Corporation announced that it has declared a quarterly cash dividend of $1.20 per share on its common stock. This represents an increase of 10c per share, or 9%, from the previous $1.10 per share dividend paid in the third quarter of 2021. The dividend will be payable December 31, 2021 to shareholders of record at the close of business on November 30, 2021.

18:41 EST Atea Pharmaceuticals' joint COVID-19 treatment with Roche to be terminated - The company states: "Atea Pharmaceuticals (AVIR) announced that the strategic collaboration pursuant to which it was jointly developing AT-527 for the treatment of COVID-19 with Roche (RHHBY) will be terminating. Upon termination, the rights and licenses granted by Atea to Roche under the strategic collaboration will be returned to Atea, and Atea will have full rights to continue the clinical development and future commercialization of AT-527 worldwide. The strategic collaboration with Roche, which included joint development, will be terminated on February 10, 2022." CEO Pierre Sommadossi says: "We believe strongly in the potential of AT-527 with its unique dual mechanism of action, antiviral activity against the major variants of concern and its market potential given the need for additional therapeutic options for COVID-19. We have the financial resources and the talent to independently drive forward the Phase 3 MORNINGSKY clinical trial program, and we continue to expect data from this trial during the second half of 2022. We are energized by the opportunity to move forward with full ownership, providing us with autonomy to efficiently bring AT-527 to market."

18:03 EST La-Z-Boy jumps 5% to $39.50 after Q2 results beat estimates

17:37 EST Users reporting issues with Roblox, says Downdetector - Reference Link

17:32 EST ODP Corp announces $150M accelerated buyback, $150M increase to current program - The ODP Corporation "announced that it has entered into accelerated share repurchase plan agreements with Goldman Sachs & Co. LLC and JPMorgan Chase Bank, National Association to repurchase an aggregate of $150M of the Company's stock. ODP will execute the ASRs under its existing stock repurchase program. When combined with the company's previously completed share repurchases, ODP will have committed to return more than $300 million of capital to shareholders in 2021. Additionally, as part of its ongoing commitment to drive shareholder value in support of its strategic initiatives, the company announced that its board authorized a $150M increase in the existing $300M stock repurchase program to $450M. Accordingly, the Company will have approximately $142M available for additional share repurchases through June 30, 2022 following entering into the $150 million ASR."

17:18 EST Retail Value announces due diligence period to sell Willowbrook Plaza expired - The company states: "Retail Value announced that the general due diligence period expired under an agreement to sell Willowbrook Plaza located in Houston, Texas to a third party purchaser for $37.1M in cash, subject to adjustment for certain closing pro-rations, allocations, credits, closing costs and escrows. Closing remains subject to customary conditions and is expected to occur by the end of 2021."

17:02 EST Berry Global enters agreement with PureCycle for supply of UPR resin - Berry Global announced an agreement with PureCycle that will provide Berry with PureCycle's Ultra-Pure Recycled, or UPR, advanced recycled resin. This agreement is the latest in a growing list of advanced recycling material sourcing announcements from Berry and is the company's second based in North America. The material will be supplied to Berry in summer 2023 for manufacturing at one of Berry's ISCC PLUS certified facilities. Berry previously announced its first three facilities in North America to achieve ISCC PLUS certification.

16:49 EST BRP Group to acquire Construction Risk Partners - BRP Group announced that Baldwin Krystyn Sherman Partners, an indirect subsidiary of BRP Group, has entered into an agreement to acquire all the outstanding equity interests of Construction Risk Partners. Based in Branchburg, New Jersey, CRP is a specialty construction brokerage firm focused on providing risk mitigation expertise and services to business owners, developers, general contractors, designers and subcontractors across the country. CRP has annual revenues of approximately $32.6M.

16:40 EST Teck Resources reports logistics chain disrupted due to heavy rain, flooding - Teck Resources (TECK) reported that its logistics chain between west coast terminals and B.C. operations has been temporarily disrupted due to heavy rain, flooding and mudslides. Teck has implemented measures to mitigate the effect of the disruption, diverting some trains to Ridley Terminals in Prince Rupert. Canadian Pacific (CP) and Canadian National (CN) have begun repairs but do not currently have estimated return to service dates. The overall impact and any potential effect on Q4 sales will be dependent on the duration of the logistics chain disruption. Production at the company's operations has not been impacted at this time.

16:34 EST Nova Measuring to acquire ancosys GmbH for $100M in cash - Nova announced that it has entered into a definitive agreement to acquire ancosys GmbH, headquartered in Pliezhausen Germany, in an all-cash transaction valued at approximately $100M, including a performance based earnout of $10M. The acquisition is subject to customary closing and regulatory conditions and approvals, and is expected to close within the first quarter of 2022. The company expects the acquisition to be accretive on a non-GAAP basis within 12 months of closing. Ancosys is a provider of chemical analysis and metrology solutions for advanced semiconductor manufacturing.

16:32 EST Yelp announces new new advertising products - The company states: "Yelp officially announced two new advertising products, Sponsored Collections, expanding Yelp Audiences campaigns to help national brands better reach a local audience both on and off the platform, and Seasonal Spotlight Ads, which helps brands reach Yelp's high-intent users right on Yelp's home screen. Sponsored Collections, which appear on the Yelp iOS app homepage, enable brands, with or without a storefront, the opportunity to showcase local businesses around a common theme. Seasonal Spotlight Ads aimed at helping multi-location brands drive in-store traffic by communicating directly with Yelp's high-intent audience about seasonal deals, promotions and new products."

16:26 EST Royal Gold raises annual dividend 17% to $1.45 or 35c on a quarterly basis - ROYAL GOLD announced that its Board of Directors increased the Company's annual calendar year common stock dividend by 17% from $1.20 to $1.40 per share, payable on a quarterly basis of 35c per share. The first quarterly dividend at the increased rate is payable on January 21, 2022, to shareholders of record at the close of business on January 7, 2022.

16:23 EST La-Z-Boy reports Q2 written SSS for entire Furniture Galleries network down 6% - Written same-store sales for the entire La-Z-Boy Furniture Galleries network: Decreased 6.0% for the fiscal 2022 second quarter compared with the unusually strong fiscal 2021 second quarter (+34% versus the fiscal 2020 second quarter) following COVID-related store closures. Compared with the pre-pandemic fiscal 2020 second quarter, written same-store sales increased 26% for the fiscal 2022 second quarter, for a compounded annual growth rate of 12% over the two years, reflecting continued significant growth in the business

16:20 EST R.R. Donnelley confirms receipt of revised Chatham proposal - R.R. Donnelley & Sons Company on November 3, 2021 announced it entered into a definitive merger agreement to be acquired by affiliates of Atlas Holdings LLC for $8.52 per share in cash for each share of RRD common stock. RRD on November 16 announced that it has received a proposal from Chatham Asset Management, LLC to acquire all of the outstanding shares of RRD not already owned by Chatham for $9.10 per share in cash. The RRD Board of Directors, consistent with its fiduciary duties and in accordance with the terms of its merger agreement with Atlas, will carefully review and consider the Revised Proposal to determine the course of action that it believes is in the best interests of the Company and RRD shareholders. RRD shareholders do not need to take any action at this time and the RRD Board of Directors has not yet made any determination with respect to the Revised Proposal.

16:17 EST La-Z-Boy CFO says 'demand trends remain strong' - Bob Lucian, CFO of La-Z-Boy Incorporated, said, "Demand trends remain strong, our backlog is high and we expect delivered sales to continue to strengthen, particularly in the fourth quarter as new production cells come online. At the same time, we expect continued supply chain disruptions, including a temporary, but significant, slowdown in our casegoods business due to COVID-related shutdowns in Vietnam. Quarterly trends will also be impacted by our third and fourth quarters containing 12 and 14 production weeks, respectively, compared to 13 production weeks in our second quarter. Taking all of these factors into consideration, we continue to expect sales and margin momentum to accelerate, particularly in the fourth quarter, and we continue to expect to deliver full-year consolidated operating margin at or near double digits."

16:16 EST Insteel declares special one-time cash dividend of $2.00 per share - The dividend is payable on December 17, 2021, to shareholders of record as of December 2, 2021.

16:09 EST CBRE Group and Altus Power to partner on proprietary application - The company states: "CBRE Group and Altus Power have partnered to develop an advanced proprietary tool to identify locally sited clean energy opportunities that help commercial real estate owners and occupiers meet their energy needs while reducing their carbon footprints. The offering leverages CBRE's vast commercial real estate data platform, advanced analytics and proprietary algorithms to identify and model clean energy opportunities for commercial & industrial properties, community solar projects, and electric vehicle charging stations. Altus Power and CBRE have developed a proprietary application that leverages artificial intelligence to rapidly identify promising rooftops from CBRE's dataset. Using CBRE's proprietary algorithms with access to advanced satellite imagery and CBRE's up-to-date information, the application can accurately model building energy demand, potential power generation and identify opportunities where solar energy and/or battery storage can be deployed to accelerate owners' and occupiers' carbon reduction efforts."

16:06 EST Ichor Holdings to acquire IMG Companies in $270M deal - Ichor Holdings announced that its wholly-owned subsidiary, Incline Merger Sub, LLC, has entered into a merger agreement with IMG Companies, LLC, a Livermore, CA-based precision machining, welding, brazing, and surface treatment business serving the semiconductor, medical, and aerospace/defense industries. The total purchase price of $270 million is being financed with approximately $140 million of cash and marketable securities on hand and $130 million of incremental borrowing, pursuant to the recent refinancing and expansion of our credit facility. The acquisition is subject to satisfaction of customary closing conditions, and is expected to close in the fourth quarter of 2021. "IMG brings to Ichor additional precision machining capabilities and capacity, as well as advanced manufacturing capabilities such as e-beam and laser welding, precision vacuum and hydrogen brazing, ceramic metallization, and precious metal coating capability," commented Jeff Andreson, CEO of Ichor. "While IMG's primary market is the semiconductor equipment industry, this acquisition will also expand Ichor's customer base, with positions in rapidly-growing segments of the medical, aerospace and defense industries. Additionally, a significant portion of IMG's revenues are derived from recurring sources such as spares and consumables. We are excited to welcome the IMG team to Ichor, and look forward to continue executing on our key growth strategies, which include complementary acquisitions that are accretive to our operating model."

16:06 EST SS&C raises quarterly dividend to 20c from 16c per share - The dividend is payable on December 15 to stockholders of record as of the close of business on December 1.

16:02 EST Magyar Bancorp announces special cash dividend of 12c - Magyar Bancorp, parent company of Magyar Bank, announced that its board of directors declared a special cash dividend of 12c per common share. The dividend will be paid to stockholders of record as of the close of business on November 30, 2021 and is expected to be paid on or about December 14. This is the first cash dividend for the Company since the completion of its second-step mutual to stock conversion and public offering in July.

15:18 EST Google says issue with Cloud Networking has been resolved - On a status page, Google Cloud states: "The issue with Cloud Networking has been resolved for all affected projects as of Tuesday, 2021-11-16 11:28 US/Pacific. Customers impacted by the issue may have encountered 404 errors when accessing web pages served by the Google External Proxy Load Balancer between 09:35 and 10:10 US/Pacific. Customer impact from 10:10 to 11:28 US/Pacific was configuration changes to External Proxy Load Balancers not taking effect. As of 11:28 US/Pacific configuration pushes resumed. Google Cloud Run, Google App Engine, Google Cloud Functions, and Apigee were also impacted. We will publish an analysis of this incident, once we have completed our internal investigation. We thank you for your patience while we worked on resolving the issue." Reference Link

14:43 EST Amkor Technology approves 25% increase in cash dividend to 5c per share - Amkor Technology announced that its board of directors has approved a 25% increase in the company's quarterly cash dividend, from 4c per share to 5c per share, on the company's common stock. This increase will be effective with the dividend payment to be distributed on December 28 to stockholders of record on December 7. "Based on our strong operating results and financial position, Amkor has increased its quarterly cash dividend by 25%. We are pleased to be in a position where we can both invest in our future and increase our return of capital to stockholders," said Giel Rutten, Amkor's president and CEO.

14:21 EST Activision board expresses confidence in Bobby Kotick's leadership - Activision Blizzard's board of directors released a statement responding to recent media stories: "The Activision Blizzard Board remains committed to the goal of making Activision Blizzard the most welcoming and inclusive company in the industry. Under Bobby Kotick's leadership the Company is already implementing industry leading changes including a zero tolerance harassment policy, a dedication to achieving significant increases to the percentages of women and non-binary people in our workforce and significant internal and external investments to accelerate opportunities for diverse talent. The Board remains confident that Bobby Kotick appropriately addressed workplace issues brought to his attention. The goals we have set for ourselves are both critical and ambitious. The Board remains confident in Bobby Kotick's leadership, commitment and ability to achieve these goals."

14:19 EST NTSB ends investigation into Tesla Model 3 accident last August - The U.S. National Transportation Safety Board ended its investigation into a fatal August 12, 2020 crash of a Tesla Model 3 vehicle in California. The NTSB said no further action will be taken. The driver of the vehicle was operating the vehicle with autopilot engaged but pressed the accelerator pedal, overriding the function, the agency said in a memo. Reference Link

14:01 EST Pfizer to seek EUA from FDA for COVID-19 oral antiviral candidate - Pfizer announced it is seeking Emergency Use Authorization of its investigational oral antiviral candidate, PAXLOVID, for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalizations or death. This submission to the U.S. Food and Drug Administration includes clinical data from the Phase 2/3 EPIC-HR interim analysis. Rolling submission of non-clinical data for PAXLOVID was initiated with the U.S. FDA in October 2021. If authorized or approved, PAXLOVID would be the first oral antiviral of its kind, a 3CL protease inhibitor specifically designed to combat SARS-CoV-2 that could be prescribed as an at-home treatment to high-risk patients at the first sign of infection, potentially helping patients avoid severe illness which can lead to hospitalization and death. "With more than 5 million deaths and countless lives impacted by this devastating disease globally, there is an urgent need for life-saving treatment options. The overwhelming efficacy achieved in our recent clinical study of PAXLOVID, and its potential to help save lives and keep people out of the hospital if authorized, underscores the critical role that oral antiviral therapies could play in the battle against COVID-19," said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. "We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world."

13:24 EST New York AG urges Starbucks to let union process proceed 'without interference' - New York Attorney General Letitia James said via Twitter: "I fully support the @SBWorkersUnited employees in Buffalo for bravely exercising their fundamental right to unionize. Any effort to intimidate these workers won't be tolerated, and I strongly urge @Starbucks to allow this process to proceed without interference."

13:14 EST Activision Blizzard worker alliance to stage walkout - ABetterABK, a workers alliance for Activision Blizzard staff, said it will be staging a walkout in the wake of a Wall Street Journal report saying CEO Bobby Kotick knew about sexual misconduct allegations at the company. "We have instituted our own Zero Tolerance Policy," the worker group said. "We will not be silenced until Bobby Kotick has been replaced as CEO, and continue to hold our original demand for Third-Party review by an employee-chosen source. We are staging a Walkout today. We welcome you to join us." Reference Link

13:11 EST Users reporting issues with Facebook, says Downdetector - https://downdetector.com/status/facebook/

13:05 EST Users reporting issues with AWS, Home Depot, Lowe's websites, says DownDetector - Reference Link

13:03 EST Users reporting issues with Spotify, says Downdetector - Reference Link

13:02 EST Blackstone announces investment in Life Sciences Logistics - Blackstone announced that funds managed by Blackstone Tactical Opportunities have entered into a definitive agreement to make a significant, strategic investment in Life Science Logistics. The investment is intended to help accelerate LSL's continued expansion within the fast-growing pharmaceutical and medical device market as it opens new facilities and further increases its customer base in the years ahead. Founded in 2006 and headquartered in Dallas, Life Science Logistics is a leading third-party healthcare logistics provider with more than 600 employees and 4 million square feet of warehousing and logistics space within 12 controlled-temperature and cold chain storage and distribution locations across nine states - from Dallas to New York to Seattle and other major hubs. The company partners with governments, global pharmaceutical and biotechnology companies and medical device providers to deliver end-to-end supply chain solutions and emergency preparedness infrastructure services across the U.S. Terms of the transaction, which is subject to customary closing conditions, were not disclosed. UBS Investment Bank served as exclusive financial advisor and McDermott, Will & Emory served as legal counsel to Life Science Logistics. Jefferies and Morgan Stanley & Co. LLC served as financial advisors and Simpson Thacher & Bartlett LLP and Sidley Austen LLP served as legal advisors to Blackstone.

12:53 EST Danimer's 'sudden opacity' stands out after 'awful' Q3, Muddy Waters says - Carson Block's Muddy Waters said via Twitter: "$DNMR - Seems the market gets that the Q3 results and call were awful. What really stands out is the sudden opacity w/r/t PHA ASP. When you're being scrutinized for obfuscation and exaggeration, you should never answer with more obfuscation...Unless the truth is really that bad!" Shares of Danimer Scientific are down 16% to $14.78 following last night's Q3 results.

12:15 EST Qualcomm sees automotive revenues of $3.5B in five years, $8B in 10 years

12:14 EST Qualcomm sees IOT sales growing as much as $9B by FY24

12:13 EST Qualcomm has two year commitments for smartphone chips from all major customers - Comments taken from the company's Investor Day event.

12:00 EST Riskified falls -21.6% - Riskified is down -21.6%, or -$3.81 to $13.87.

12:00 EST Kuke Music rises 15.6% - Kuke Music is up 15.6%, or 64c to $4.75.

12:00 EST On Holding rises 19.9% - On Holding is up 19.9%, or $7.24 to $43.67.

11:15 EST Activision drops 3% after WSJ says CEO Kotick knew of assault allegations

11:00 EST U.S. Bancorp to acquire San Francisco-based fintech company TravelBank - U.S. Bancorp, the parent company of U.S. Bank, has entered into an agreement to acquire TravelBank, a San Francisco-based fintech company that provides an all-in-one, tech-driven expense and travel management solution. "We are focused on giving businesses more confidence, control and convenience in managing payments and expenses. TravelBank will help us accelerate these efforts," said Shailesh Kotwal, vice chair of Payment Services at U.S. Bank. "In partnering with TravelBank over the past year, we've seen how effective the solution is in improving efficiencies for businesses. This acquisition will allow us to significantly expand our client base and deliver even more value to our customers." The purchase agreement with TravelBank was signed on November 14, 2021 and the transaction is expected to close in the fourth quarter of this year. Financial details of the transaction were not disclosed.

10:17 EST Poshmark appoints Rodrigo Brumana as CFO - Earlier, Poshmark (POSH) announced the appointment of Rodrigo Brumana as Chief Financial Officer, effective December 1. As CFO, Brumana will be responsible for the company's global finance function, including financial planning and analysis, budgeting and forecasting, accounting, internal audit, tax and treasury, and investor relations. Brumana will join Poshmark from Amazon (AMZN), where he served as CFO of Amazon Private Brands, managing a team of finance, business intelligence and analytics professionals located across the Americas, Asia, and Europe supporting product development, marketing, category management, discovery, pricing, technology, science, supply chain and sourcing.

10:15 EST Qiagen up 5% after Betaville reports on takeover rumor - Shares of Qiagen (QGEN) are up 5% to $55.90 in early trading after Ben Harrington's M&A-focused Betaville blog issued a "Rare Alert" regarding the company. The report is said, according to Bloomberg, to mention rumors that Thermo Fisher (TMO) may come back with a fresh takeover bid for its rival after Qiagen's board twice last year recommended such a takeover and the deal did not go through. On the blog, Harrington defines a "Rare Alert" as "Market gossip that has been tested with some of Betaville's USUALLY WELL-INFORMED sources. In fact, Betaville might have spent several days or weeks working on this story. However, the rumour hasn't been tested through formal journalistic channels (public relations executives, bankers etc). The scuttlebutt might be complete codswallop - but then again there may be something in it, so it's worth airing on Betaville." Reference Link

10:04 EST Creatd jumps 2% to $3.19 after Q3 results, confirmed FY21 outlook

10:00 EST Danimer Scientific falls -15.8% - Danimer Scientific is down -15.8%, or -$2.81 to $14.92.

10:00 EST Beachbody Company falls -21.9% - Beachbody Company is down -21.9%, or -$1.01 to $3.61.

10:00 EST Romeo Power rises 18.7% - Romeo Power is up 18.7%, or 83c to $5.26.

10:00 EST On Holding rises 20.4% - On Holding is up 20.4%, or $7.42 to $43.85.

09:47 EST Desktop Metal falls -14.0% - Desktop Metal is down -14.0%, or -$1.12 to $6.90.

09:47 EST Beachbody Company falls -25.5% - Beachbody Company is down -25.5%, or -$1.18 to $3.44.

09:47 EST Romeo Power rises 10.6% - Romeo Power is up 10.6%, or 47c to $4.90.

09:38 EST Verizon announces new feature for calling via Alexa at Home - Verizon (VZ) announced that its customers now can get "Number Share - Home," which it identifies as a new feature that allows customers to make and receive hands-free audio calls through their supported Amazon (AMZN) Alexa-enabled devices, such as Echo, Echo Dot, and Echo Show. "Verizon customers who sign up for Number Share - Home and purchase an Alexa-enabled device from Verizon will receive three months on us. Number Share - Home creates a powerful tool of convenience for Verizon customers to make calls via their smart speakers," Verizon stated.

09:30 EST MercadoLibre announces pricing of equity offering - MercadoLibre announced the pricing of an underwritten public offering of 1,000,000 shares of common stock at a public offering price of $1,550.00 per share, for aggregate proceeds before underwriting discount and expenses of $1.55 billion. In addition, the underwriters have a 30-day option to purchase up to an additional 150,000 shares of common stock.

09:29 EST Uber up 4% after CEO buys 200,000 shares - Uber CEO Dara Khosrowshahi disclosed in a regulatory filing earlier that he purchased 200,000 shares of the company's common stock on November 15 at an average price of about $44.92 in multiple transactions at prices ranging from $44.62 to $45.07, inclusive. In pre-market trading, Uber shares are up $.179, or 4%, to $45.40.

09:27 EST Reed's launches limited-edition Ginger Ale at Costco - Reed's (REED) announced the launch of Reed's REAL Cranberry Ginger Ale, an exclusive variety for Costco (COST) members in the Northwest region. "After an overwhelmingly positive response from consumers to our Reed's REAL Ginger Ale, we were inspired to take our premium recipe and add an exciting seasonal twist on it for the holiday season," shared Norman E. Snyder, CEO of Reed's Inc.(R) "We're thrilled to bring our ginger-loving fans this limited-edition flavor and look forward to continuing to expand upon our ginger beverage portfolio in 2022." Reed's REAL Cranberry Ginger Ale is currently available in-store at 70 Costco locations throughout the Northwest region including WA, OR, ID, MT, AK and UT.

09:25 EST Aware announces Thomas County, GA adopted AwareBIS - Aware announces that the Thomas County, GA sheriff's office has installed its AwareABIS Automated Biometric Identification System, ABIS. Designed for ten-print, palm print, latent print and mug shot searches, AwareABIS enables law enforcement agencies with advanced forensic search, analysis and reporting. With AwareABIS, Thomas County law enforcement can now identify wanted individuals and search crime scene finger and palm prints faster. "There has long been a need for a new ABIS product in the market and we are happy to provide one to Thomas County," said Robert Mungovan, chief commercial officer at Aware. "With AwareABIS, Thomas County now has a biometric identification system that enables them to best manage and optimize their booking and forensic processes. They are not locked into expensive, long-term contracts and, of course, they benefit from the better control of their data and their workflows that AwareABIS provides."

09:24 EST Blink Charging appoints Dobrikova as Vice President of Fleet Solutions - Blink Charging announced the appointment of transportation and automotive industry executive, Amy Dobrikova as Vice President of Fleet Solutions. "The appointment of Dobrikova signals the Company's focus on expanding its product line and services to better serve public and private fleets, a sector critical to the energy transition and primed for electrification, nationwide," the company said. Prior to joining Blink, Dobrikova most recently served as Vice President of Channel Sales at Cardone Industries, an aftermarket auto parts manufacturer.

09:22 EST Biogen announces EC granted marketing authorization for VUMERITY - Biogen announced that the European Commission, EC, has granted marketing authorization for VUMERITY to treat adults with relapsing-remitting multiple sclerosis, MS. VUMERITY is a next-generation fumarate that offers the convenience of an oral medication with the established efficacy and well-characterized safety of TECFIDERA. The EC's approval of VUMERITY is based on data from pharmacokinetic bridging studies comparing VUMERITY and TECFIDERA to establish bioequivalent exposure of monomethyl fumarate, the active metabolite, and relied in part on the well-established long-term efficacy and safety profile of TECFIDERA. The approval was also based on findings from EVOLVE-MS-2, a large, randomized, double-blind, five-week, multi-center Phase 3 study to evaluate the gastrointestinal tolerability of VUMERITY compared to TECFIDERA in patients with relapsing-remitting MS. "This approval is a significant step forward in improving treatment adherence for people living with relapsing MS, which can make a meaningful difference on treatment outcomes impacting their daily lives," said Maha Radhakrishnan, M.D., Chief Medical Officer at Biogen. "The authorization of VUMERITY in the EU brings people with MS a new oral treatment option to meet their individual preferences and needs, with well-established efficacy and a positive GI tolerability profile that continues to be evaluated in the real-world setting." VUMERITY was first approved by the U.S. Food and Drug Administration in October 2019 and is also approved in Great Britain and Switzerland.

09:20 EST Nano Dimension appoints Greg Caldwell as VP, global marketing - Nano Dimension (NNDM) announced today that Greg Caldwell has joined as Vice President of Global Marketing, reporting to Zivi Nedivi, Global President of Nano Dimension. Most recently, he was Head of Global Marketing and Sales Enablement at Anark Corporation and Vice President, Marketing and Communications at 3D Systems (DDD). At Nano Dimension, Mr. Caldwell will lead the development of a global marketing organization that will have a footprint in the Americas, Europe, the Middle East, and Asia-Pacific. He will focus on the development and delivery of Nano Dimension's message to customers and prospects, emphasizing the innovation and disruption that Nano Dimension is driving in additively manufactured industries, such as electronics and micro mechanics.

09:20 EST Home Depot reports Q3 gross margin 34.1%, down 5 bps y/y - Cites transportation and other increased costs. Targets CapEx at 2% of sales annually.

09:18 EST Great Lakes signs contract with Philly Shipyard - Great Lakes Dredge & Dock announced today that the Company has signed a contract with Philly Shipyard to build the first U.S.-flagged Jones Act-compliant, inclined fallpipe vessel for subsea rock installation. This vessel will service America's growing offshore wind energy industry and help reach the Biden administration's ambitious 30 GW of offshore wind goal by 2030. "This contract, valued at approximately $197 million, marks a milestone for our company, the U.S. offshore wind industry and our nation," said Lasse Petterson, Great Lakes Dredge & Dock's President and Chief Executive Officer. "Offshore wind will play a crucial role in helping the U.S. meet its decarbonization and clean energy goals. The unique, technologically advanced vessel we are constructing is an essential step towards building the marine infrastructure required for this new industry, which holds so much promise for our nation economically and environmentally." This Great Lakes Dredge & Dock vessel will be U.S. owned, U.S. built, U.S. operated and crewed by American union workers, and will meet all conditions of the Jones Act. The vessel will transport and strategically deposit loads of rock on the seabed, laying scour protection for offshore wind farm foundations, cables and other structures.

09:15 EST Jupiter Wellness announces results of JW-300 trial for 1st degree burns - Jupiter Wellness announced the results of a double-blinded placebo controlled trial of JW-300 for the treatment of first degree burns. The JW-300 Clinical Trial included thirty-six patients who completed the study in which a controlled area of the skin was exposed to UV irradiation in the presence or absence of the JW-300 lotion. The results demonstrated that the percent of subjects experiencing burns in patients treated with JW-300 was significantly lowe than in subjects receiving the placebo lotion. The percent of subjects that were burned in the placebo arm was 61% compared to 27% in patients treated with the JW-300. In addition, patients treated with JW-300 the average erythema score was 0.388 after radiation compared to 0.722 in the placebo arm . "These encouraging results show the potential of JW-300 for the prevention and potentially the treatment of burns including sunburn," stated Jupiter Wellness Chief Scientific Officer, Dr. Glynn Wilson. "JW-300 complements and has the potential to expand our current product lines which include CaniSun and Photocil that are clinically proven and designed to protect, treat, and achieve therapeutic balance in skincare health. The treatment of burns including sunburn are important indications with unmet needs, particularly in the OTC market where we see a significant opportunity for JW-300." The burn care market was valued at $2.1B in 2020 and is expected to grow at a CAGR of 7% from 2021 to 2028 driven by rising incidence of burns, favorable reimbursement policies, and technological advancement.

09:14 EST Atlanticus Holdings board approves quarterly preferred stock dividend - Atlanticus Holdings Corporation announced that its Board of Directors approved a quarterly dividend of $0.4765625 per share to Series B Cumulative Perpetual Preferred stockholders. The cash dividend will be paid on or about December 15, 2021 to holders of record of Atlanticus' Series B Cumulative Perpetual Preferred Stock on the close of business on December 1, 2021.

09:12 EST Cardinal Health collaborate with Zipline for automated deliveries to pharmacies - Cardinal Health and Zipline announced a collaboration to offer on-demand autonomous aircraft delivery to pharmacies. Cardinal Health will use Zipline's service for on-demand replenishment of pharmaceutical and medical products to retail pharmacy locations. The operation aims to help mitigate risk of inventory stock-outs for certain products and deliver to customers the right products at the right time for their patients. Cardinal Health and Zipline will launch operations in North Carolina that will aim to receive orders and make deliveries of certain products in just 15-30 minutes. The companies plan to expand to additional locations following the initial launch.

09:11 EST Gevo signs MoU with Sweetwater Energy for supply of lignocellulosic feedstocks - Gevo announces it has signed a memorandum of understanding, MoU, with Sweetwater Energy regarding the use of sustainably sourced agricultural residues and woody biomass as a feedstock for producing cellulosic alcohols and energy-dense renewable liquid hydrocarbons. As outlined in the MoU, Sweetwater plans to build, own and operate a facility adjacent to Gevo's existing plant in Luverne, Minnesota to produce high-value, plant-based products from cellulose and lignin while supplying Gevo with up to 30,000 tons of biomass-derived cellulosic sugars annually, with opportunities for expansion. The new Sweetwater facility would utilize its proprietary Sunburst technology for deconstructing lignocellulosic biomass. Sweetwater's anticipated plant-based product portfolio, derived from cellulose and lignin, is targeted for applications in packaging, resins, and other applications to increase performance and sustainability, while displacing petroleum-based products. Gevo plans to use the offtake of the low-cost, cellulosic sugars co-produced by Sweetwater for the anticipated production of cellulosic alcohols and renewable hydrocarbons. "Combining forces with Sweetwater is a great way to leverage the best technology and resources from both parties to expand our addressable feedstocks to produce cellulosic alcohols and energy dense hydrocarbon fuels and plant-based products," says Dr. Paul Bloom, Chief Carbon and Innovation Officer of Gevo. "Working together we anticipate delivering products to the market faster while decreasing risk throughout the value chain and lowering overall product carbon intensities through a systems approach to decarbonization. This is an important step to expand the portfolio of carbohydrates we intend to process to include cellulosic sugars that represent a huge amount of feedstock globally."

09:10 EST Comtech awarded $3.7M of funding for Maryland's Dept of Human Services - Comtech Telecommunications announced , that during its first quarter of fiscal 2022, it was awarded $3.7M of funding to provide the State of Maryland Department of Human Services with statewide Technical Operations Support Services . Comtech and its experienced team members work directly with the personnel of DHS to develop, maintain and support the IT needs of DHS. "Through our provisioning of high quality IT services on a consistent basis, we've become a trusted partner to the State of Maryland DHS. We look forward to continuing to provide service at an optimal level to all state agencies included in this extension of the contract," said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp. The Maryland DHS is the state's primary social service provider, annually reaching more than one million people. Through its 24 local departments

09:07 EST Pacific Biosciences launches HiFiViral SARS-CoV-2 Kit - PacBio announced the launch of the HiFiViral SARS-CoV-2 Kit - a fully kitted end-to-end solution for COVID-19 surveillance, which public health laboratories can use to identify new SARS-CoV-2 variants and detect all variants circulating within a population. The HiFiViral SARS-CoV-2 Kit is PacBio's first kitted solution for genomic surveillance of COVID-19 variants. The assay leverages PacBio's trusted HiFi sequencing to give researchers a more complete view of novel mutations of all types, ensuring that emerging variants are captured.

09:06 EST Adtalem Global in pact with with Society of Teachers of Family Medicine - The Adtalem Global Education Foundation has announced a two-year strategic partnership with the Society of Teachers of Family Medicine or STFM, a national community of academic leaders committed to developing an accomplished family medicine workforce prepared to serve as the foundation of America's health care system. With a two-year commitment of $180,750, the Adtalem Global Education Foundation will serve as the lead philanthropic partner for STFM's Academic Family Medicine Antiracism Learning Collaborative, a project to: Empower and educate faculty, so they will identify racist structures and behaviors within their academic institutions and become leaders for change;Promote allyship; Spread effective change strategies. "Adtalem is committed to combatting inequality and encouraging civic engagement across the entirety of the healthcare sector," said Stephen Beard, president and CEO of Adtalem Global Education. "This partnership between the Adtalem Global Education Foundation and STFM strategically aligns with that commitment. Supporting and taking part in this national collaborative will help leaders and changemakers across the industry, including our own faculty participants, identify new approaches to combatting structural racism in medicine and improve health outcomes and equity by reducing disparities."

09:05 EST Cerner appoints Nasim Afsar as chief health officer - Cerner Corporation announced Nasim Afsar, MD, MBA, MHM, as the company's first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner's more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality and patient safety, regulatory, health policy, government affairs and continuous improvement organizations. Afsar is an experienced physician and healthcare executive with more than a decade of leadership responsibilities in large complex healthcare delivery systems, including UCLA Health and UCI Health. Previously, she has served as Chief Operating Officer, Chief Quality Officer and Associate Chief Medical Officer, delivering large scale and sustainable outcomes in quality, population health management, operations, finance, contracting, business development and strategy.

09:05 EST Beachbody brings Openfit content to Google TV and Android TV devices - The Beachbody announced the availability of its Openfit content to 80M monthly active Google (GOOG) TV and Android TV devices, extending the company's position as the leading provider of accessible, affordable and engaging at-home fitness content. Google TV and other Android TV users will have a way to engage with Openfit's all-in-one digital fitness, nutrition and wellness platform.

09:03 EST UPS Healthcare announces new set of facilities, continues global expansion - UPS Healthcare announced a new set of facilities and continued round of global expansion designed to bring unprecedented capabilities to global healthcare logistics customers. The newest cold chain and packaging centers opens in Louisville, Kentucky, located on the UPS Healthcare campus near the Worldport global air hub. "Our decades of experience create the perfect foundation for continued investment in capabilities and infrastructure around the world," said Chief Sales and Solutions Officer and Executive Vice President, UPS Global Healthcare Kate Gutmann. "UPS Healthcare is on a mission to provide our customers with even higher performance, greater cost efficiencies, and more sustainable shipping options." UPS's success with COVID-19 vaccine delivery is creating long-term value in the future delivery of new drugs, especially biologics. The company's temperature-controlled facilities are designed to handle biologically derived drugs, such as vaccines, at any temperature. The newest facility, named the 'Cold Chain Packaging Center of Excellence,' is the company's first U.S.-based logistics facility to offer reusable cold chain packaging options for customers.

09:02 EST SeaWorld to open eleven new rides and attractions across ten parks in 2022 - SeaWorld Parks & Entertainment announced that 11 new thrilling rides and attractions will open in 10 parks, the largest number of new attractions ever introduced in a single year by the company. The new thrills include some of the steepest, tallest, fastest coasters of their kind in North America and the world. In addition to new attractions, a new park is set to open on the West Coast in March 2022 - Sesame Place San Diego.

08:56 EST Hepion, FibroFind announce results from research study of CRV431 - Hepion Pharmaceuticals announced the results of a nonclinical research study showing that CRV431 significantly decreased the growth of liver tumors in a mouse model of liver cancer. Additionally, CRV431 was as effective at decreasing tumor burden as an anti-PD1 antibody immune checkpoint inhibitor, PD1 antibody, and produced more beneficial changes in tumor infiltrating cells compared to anti-PD1 antibody treatment. The study was conducted by FibroFind in collaboration with Professor Derek Mann, Dean of Research and Innovation at Newcastle University. In this study, mouse hepatocellular cancer cells were surgically implanted into livers of recipient mice. In the absence of drug treatment, large tumors developed over a period of 28 days. Drug treatments began in the treatment groups on Day 14 after HCC hep53.4 cell implantation, when the tumors had reached approximately 15% of their final size. Mice received either once-daily CRV431, administered orally, or a single dose anti-PD1 antibody, administered intraperitoneally. An additional treatment arm examined a CRV431/anti-PD1 antibody combination treatment. Drug dosing continued for a total of two weeks and the changes in tumor volumes were measured from the initiation of drug treatment to the end of the experiment. Treatment with CRV431 or an anti-PD1 antibody each decreased tumor size by 76%, while the CRV431/anti-PDI antibody combination treatment decreased tumor size by 83%, compared to the vehicle treatment.Microscopic examination of the tumors showed that CRV431 beneficially doubled the number of tumor-infiltrating CD4 and CD8 lymphocytes. This same finding was observed with anti-PD1 treatment, suggesting that both treatments stimulated immunity against the tumors. Furthermore, CRV431 decreased the number of neutrophils in the tumors by 55%, which was not observed with anti-PD1 antibody treatment. Because neutrophil-mediated inflammation frequently promotes tumor growth, CRV431's demonstrated reduction in neutrophils represents an additional anti-tumor effect. Finally, a marker of cell proliferation indicated that both CRV431 and the anti-PD1 antibody decreased tumor cell proliferation to similar degrees. These results complement previously published findings of CRV431's anti-tumor activity in a different HCC model in which liver tumors developed spontaneously in mice with long-term, diabetes-associated, NASH-like disease.

08:53 EST Global Water Resources promotes Joanne Ellsworth to EVP, corporate affairs - Global Water Resources has promoted Joanne Ellsworth to the new position of executive vice president of corporate affairs. Ellsworth previously served as the company's vice president of corporate and regulatory affairs, where she played a key role in corporate transactions and advancing the company's communication, growth services and regulatory strategy.

08:51 EST SharpLink Gaming, Quintar partner to produce immersive sports betting experience - SharpLink Gaming and Quintar jointly announced that the companies have agreed to partner to integrate their respective technologies to produce an AR experience that combines live sporting events with real-time sports betting for sports fans. SharpLink's technology development team will work with Quintar's team to create a fully turnkey platform that will allow sports bettors to participate in live sports events via AR, check game data, compare betting lines, socialize with friends and place bets with multiple sportsbook operators. In addition to integrating their respective proprietary technologies - SharpLink's C4 engine and Quintar's Q.reality - SharpLink is tasked with architecting the backend gamification features, including registration, scoring, grading and leaderboard, among other technical elements. "This is truly game-changing innovation at its finest and will result in SharpLink and Quintar delivering sports fans with an unprecedented, interactive, game day experience when engaging with and betting on their favorite sports, teams and players," said Rob Phythian, Co-Founder and CEO of SharpLink. "I have known Jay and Jeff for years and firmly share their belief that through development of cutting-edge technology, the opportunity in AR-enhanced online sports betting could be highly disruptive to the industry. Moreover, given our combined industry experience and similar spheres of influence with key decision makers in sports media, we also share the belief that growth opportunities for both our companies could prove to be potentially limitless in the long-term."

08:49 EST Latch announces partner products with several companies - Latch (LTCH) announced new partnerships with Marks, a division of NAPCO Security Technologies (NSSC), and TownSteel, along with an intended partnership with dormakaba Holding. The combination of these partnerships should bring LatchOS to more residents, property managers, and guests, and help accelerate Latch's growth across new market segments, lock formats, and verticals. "From the beginning, our vision for Latch has been much broader than access. Our value is in delivering holistic, open solutions that drive user engagement and transform the way people experience the spaces where they live, work, and visit," said Luke Schoenfelder, Latch Co-Founder, CEO, and Chairman of the Board of Directors. "As we continue to scale our business, we are excited to bring the power of LatchOS to even more spaces, doors, and people around the world. We are thrilled to partner with these industry leaders to help us accelerate our path forward and meet the rapidly growing market demand for LatchOS." Initial offerings are expected to focus on:Growing new market segments: Marks and Latch plan to launch a new Latch Lens integration with the Marks ArchiTech Series Networx Locks; Delivering new lock formats:TownSteel and Latch plan to deliver an interconnect lock powered by the Latch Lens; Driving geographic expansion: dormakaba and Latch plan to launch a new integration between dormakaba's resivo connected access devices and LatchOS to bring the full Latch software experience to new and existing dormakaba customers across Europe.

08:46 EST Eros STX in talks to sell STX Entertainment subsidiary, extend STX debt - Eros STX Global announced that it has entered into exclusive negotiations with a third party for the sale of its STX Entertainment subsidiary, during which the parties will conduct mutual diligence and negotiate definitive agreements. The Company has engaged Lazard as a financial advisor to assist in the sale process. There can be no assurance that the negotiations or any process will result in a transaction. The Company does not intend to provide announcements or updates unless or until it determines that further disclosure is appropriate or necessary.On November 12 STX Financing a wholly owned indirect subsidiary of the Company, entered into an amendment to its Senior Credit Agreemen to, among other things, extend both the maturity date and the delivery date of financial statements under the Credit Agreement to December 3. These dates may be further extended to January 4, 2022 if the Company has executed definitive agreements to sell the Company's STX Entertainment subsidiary prior to December 3 and may be further extended to February 3, 2022 if such definitive sale agreements remain in effect on January 4, 2022. As of November 12 , $127.4M remained outstanding under the Credit Agreement. On November 12 STX Financing entered into an amendment to its subordinated credit agreement to, among other things, permit STX to promptly deliver the required financial statements once they become available. As of November 12, 2021, $23.4M remained outstanding under the Mezzanine Facility. The Mezzanine Facility is set to mature on July 7 .

08:43 EST Cellectar Biosciences announces data from Phase 1 study of iopofosine I-131 - Cellectar Biosciences announced that patients in a Phase 1 study of iopofosine I-131 in children and adolescents with relapsed and refractory high grade gliomas and soft tissue sarcomas, exhibited positive changes in various tumor parameters. The Phase 1 study is an international, open-label, dose escalation, safety study of iopofosine in children and adolescents with relapsed or refractory cancers, specifically HGGs, high risk neuroblastoma and select soft tissue sarcomas. The independent data monitoring committee had previously determined that doses up to 60 mCi/m2 were safe and tolerable and to initiate the 75 mCi/m2 dosing cohort. The DMC advised, based upon the initial data, to enrich the 60 mCi/m2 dose level for patients over the age of 10 with HGG and Ewing sarcoma. The initial response and tumor uptake were confirmed by further therapeutic responses, evidenced by changes in tumor parameters. This includes patients with relapsed HGGs experiencing over 5 months of progression free survival. Pediatric HGGs are a collection of aggressive brain and central nervous system tumor subtypes including diffuse intrinsic pontine gliomas, glioblastomas, astrocytomas and ependymomas. Children with these tumors have a poor prognosis and 5-year survival of less than 30%.

08:42 EST Crispr Therapeutics, ViaCyte announce Health Canada approval for VCTX210 CTA - CRISPR Therapeutics and ViaCyte announced that Health Canada has approved the companies' Clinical Trial Application for VCTX210, an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes. Initiation of patient enrollment is expected by year-end. The Phase 1 clinical trial of VCTX210 is designed to assess its safety, tolerability, and immune evasion in patients with T1D. This program is being advanced by CRISPR Therapeutics and ViaCyte as part of a strategic collaboration for the discovery, development, and commercialization of gene-edited stem cell therapies for the treatment of diabetes. VCTX210 is an allogeneic, gene-edited, stem cell-derived product developed by applying CRISPR Therapeutics' gene-editing technology to ViaCyte's proprietary stem cell capabilities and has the potential to enable a beta-cell replacement product that may deliver durable benefit to patients without requiring concurrent immune suppression.

08:39 EST Paltalk launches Paltalk Feed message board function - Paltalk is pleased to announce it has added a message board feature to its Paltalk platform named the "Paltalk Feed". The company said, "Paltalk continues to build upon its success as an established scalable video platform and is proud to launch a real-time asynchronous message board granting users the ability to interact with the platform without a live video cam. This functionality has been absent from the Paltalk platform, and we believe the addition of the Paltalk Feed feature will increase usage of our applications. The functionality of the new feature allows users to comment, add photos or videos and contribute to conversations around shared interests on a digital message board. These comments can be shared at the user's option with either friends of the user or the entire Paltalk community. The new message board feature is designed to support increased user engagement, which we hope will create incremental revenue and income growth for Paltalk and further contribute to the Company's healthy balance sheet, and positive cash flow in the future. The entrepreneurial management team is excited about the progress of the Company and expects the new message board feature to increase user engagement across all client types. Paltalk will also engage with popular platform influencers to drive usage of the new message board feature."

08:38 EST Heritage Global teams with Branford Group & Williston Asset for auction - Heritage Global Partners a subsidiary of Heritage Global announced, that in conjunction with The Branford Group and Williston Asset Management, it will conduct an online auction of late model surplus assets from a Molded Fiber Glass Companies' Aberdeen, South Dakota site. The online auction will open on December 14 and will close on December 15, 2021. The sale catalog is currently posted with equipment photos, descriptions and links to the auction registration. Matt DelGuidice, Senior Vice President at HGP commented, "This is a great opportunity to buy well maintained assets from a world class operation, in a spotless environment. The assets are like new and we expect tremendous buyer interest. Register early and don't miss out on this opportunity." Key Assets Include:

08:34 EST Color Star signs memorandum of cooperation with National Glory Holdings - Color Star Technology announced that the Company formally signed a memorandum of cooperation with National Glory Holdings. Color Star and National Glory will conduct in-depth cooperation on metaverse and non-fungible token, or NFT, related business sectors. National Glory is an international investment holding company that focuses on real estate, venture capital, and the development and utilization of blockchain technology. The cooperation will help enhance the Company's international business network.

08:32 EST Hoth Therapeutics signs agreement with NC State University to develop HT-KIT - Hoth Therapeutics announced that it has signed a Sponsored Research Agreement with North Carolina State University, or NC State, to support the continued research and development of HT-KIT, a novel therapeutic for the treatment mast cell cancers. The research will be led by Glenn Cruse, Assistant Professor, and will focus on characterizing the HT-KIT dose and dosing frequency for treatment of aggressive mastocytosis and mast cell neoplasms using humanized tumor mouse models. In addition, the research will expand therapeutic potential of HT-KIT for the treatment of other cancers where aberrant cKIT signaling contributes to the cancer progression, such as gastrointestinal stromal tumors and acute myeloid leukemia.

08:30 EST Intema receives TSXV conditional approval for Livestream Gaming acquisition - Intema Solutions is pleased to announce that it has received conditional approval from the TSX Venture Exchange for the acquisition of all of the issued and outstanding securities in the capital of Livestream Gaming. Having received the Conditional Approval, Intema anticipates its common shares will resume trading in the near future. The completion of the Proposed Transaction remains subject to final approval by the TSXV and fulfillment of TSXV requirements, including among other things: obtaining a gaming license pursuant to the Online Gambling Regulation Act 2001 of the Isle of Man prior to the closing of the acquisition of Livestream, and filing on SEDAR of a filing statement, which will include the audited financial statements of Livestream for the year ended December 31, 2020 and the interim unaudited financial statements as at September 30, 2021 with comparatives and pro forma financial statements. In connection with the Proposed Transaction, the Corporation intends to change its name to "React Gaming Group Inc." The name change will be effective at the closing of the Proposed Transaction and is subject to shareholder approval. Intema and Livestream continue to progress towards the closing of the Proposed Transaction as previously announced. Its due diligence is completed, the definitive share purchase agreement is being finalized and the Corporation expects to have its Isle of Man gaming license hearing on December 9, 2021. Livestream is a private corporation which owns LOOT.BET, a Curacao licensed server-based real-money gaming platform and website, and a top brand in the world of esports betting.

08:22 EST The Metals Company in pact with Kongsberg ahead of Atlantic Ocean drive test - The Metals Company entered into an agreement with Kongsberg Digital, a provider of high-technology systems and solutions for the oil and gas, merchant marine, defense and aerospace industries. In advance of TMC's initial nodule collector drive test in the Atlantic Ocean planned for early next year and followed by full pilot collection system trials in the Pacific Ocean later in 2022, the parties intend to create a digital twin to enable 3D visualization of deep-sea operations in a dynamic dashboard for review by various stakeholders. The digital twin will integrate vessel information from the surface support vessel Hidden Gem with data collected from the pilot nodule collector robot and riser system, as well as data collected by independent scientists aboard a test monitoring vessel. Once completed and validated, the digital twin will be a core component of TMC's future Adaptive Management System . The Company plans to build out its AMS as an iterative and predictive state-of-the-art system that will use environmental and operational data to enable TMC to keep its deep-sea activities within ecological thresholds expected to be set by the International Seabed Authority. The AMS will draw on expert opinion and machine learning to improve operational efficiencies and reduce the uncertainty of the environmental impact over time. Gerard Barron, Chairman and CEO of The Metals Company, said: "Polymetallic nodules sit on the seafloor in complete darkness at 4-km depths but we plan to collect them in clear sight and in a manner that is accessible and accountable to the regulator and stakeholders from anywhere in the world. The Digital Twin will give us visibility - that's the first critical step. From there, we will keep gathering data, learning, predicting, and adapting our operations with environmental protection and operational efficiency in mind. This is a mission-critical system for us, and we could not have chosen a better, more experienced partner than Kongsberg Digital."

08:20 EST authID.ai appoints Neepa Patel to board of directors - authID.ai has named Neepa Patel to its Board of Directors. She will become the company's fifth independent director, joining seven other executives from senior managerial roles spanning IT consulting, operations, risk, accounting, and financial services. Since 2020, she has served as CEO of Themis, a digital governance and compliance solutions provider she founded.

08:19 EST Vocera collaborates with Amazon to build Vocera skill for Alexa - Vocera Communications (VCRA) announced it collaborated with Amazon (AMZN) to build a Vocera skill for Alexa. The skill leverages a set of technologies from Alexa Smart Properties and will be HIPAA-eligible for healthcare customers. The Vocera skill for Alexa will expand the Vocera ecosystem to provide a hands-free and immersive voice experience to patients and families. The new Vocera skill for Alexa is designed to make it easier and faster for patients and families to get information about their stay and reach the right care team members with simple voice requests spoken to an Amazon Echo in the patient's room. The intelligent solution is also designed to reduce unnecessary interruptions to the care team and minimize cognitive overload among clinicians. "We believe the intuitive and accessible nature of voice and Alexa has the potential to help and delight customers in many scenarios, in and outside of the home," said Liron Torres, Head of Alexa Smart Properties, Amazon. "We're excited to work with Vocera and extend the voice experiences customers already love to healthcare systems, and give care providers new ways to save time and personalize care for their patients." The Vocera skill for Alexa will advance the patient experience offered in hospitals and health systems. Patient requests will be delivered to the appropriate team member on their device of choice, including the Vocera Badge, Smartbadge, or Vina smartphone application. The Vocera skill for Alexa will recognize keywords and phrases and use Vocera Engage software to determine the appropriate person to receive the message, thereby reducing interruptions and streamlining workflow.

08:18 EST Enphase Energy to acquire ClipperCreek - Enphase Energy announced that it has agreed to acquire ClipperCreek. ClipperCreek offers electric vehicle, EV, charging solutions for residential and commercial customers in the U.S. This acquisition extends Enphase leadership into home electrification. The acquisition is expected to provide the following benefits: provides Enphase distributors and installers globally with EV charging solutions that can be sold alongside solar and battery systems; launches Enphase into the growing EV sector; accelerates the Enphase roadmap to enable bi-directional charging capability for vehicle-to-home and vehicle-to-grid applications; and establishes a domestic manufacturing footprint for Enphase. "We were immediately drawn to ClipperCreek's strong consumer brand, excellent product quality, and emphasis on customer experience," said Badri Kothandaraman, president and CEO of Enphase Energy. "Jason has managed to build one of the leading EV charging companies, while remaining profitable and demonstrating gross margins in-line with Enphase. We are very excited to introduce ClipperCreek to our distributors and installers around the world. We look forward to building upon the current product base while adding smart features such as cloud connectivity, integration into the EnsembleOS platform and bi-directional charging in the future. Managing EV charging is an integral part of our strategy." The acquisition is subject to customary closing conditions and regulatory approvals and is expected to close by December 31, 2021.

08:15 EST Foothills Exploration provides Wind River Basin update - Foothills Exploration is pleased to announce a corporate update. The Company has acquired an additional 2,500 acres in the Wind River Prospect, bringing the total project area up to approximately 18,887 acres. After receiving encouraging results for Phase 1 of its soil geochemical survey on a portion of the Company's acreage in the Beaver Creek East project in Fremont County, Wyoming, Phase 2 has commenced and will further analyze 95 of the 194 soil samples collected using the Synchronous Scanned Fluorescence method to reveal crude oil concentrations down to one part per million and the composition of leaking hydrocarbon source. Phase 2 should be completed within the next 7-10 business days. Licensed preliminary 2D seismic interpretation on the BCE project has confirmed the "Sand Draw Anticline" nose believed to exist on project from well data, mapping, references and published Wyoming Geological Survey cross-section. The promising structural features expected are clearly identified and bounding east and west by locally mapped faults, which help confirm the proposed initial Unit development well pad surveying and proposed Unit outlined "resource play." Deeper pay structures have been identified and are being examined by the Company's technical team. The Company will look to increase its acreage position in the project area based on its most recent analysis and geological model. Work-over operations on the Sears-Houser #4 well have commenced with the objective of producing from the Aux Vases Sand formation. The Company is scheduled to close on its recently announced acquisition of 20 oil wells and 4 Class II salt water disposal injection wells in the Illinois basin by the end of November. The agreement between the parties has an effective date of October 1, 2021. The plan is to begin a field wide optimization program once the transaction closes. The Company leased 640 acres in the Hallville field and is currently developing a shallow drilling project. The development prospect is located in Sweetwater, Wyoming, and is currently undergoing a thorough geological analysis. Drone Joint Venture with Perspectum Drone Inspection Services Ltd.: The project has been financed and the name of the joint venture is HHE Exploration Technologies, Ltd., a corporation duly organized in the Province of Alberta, Canada. The joint venture seeks to develop and commercialize a drone-based hydrogen and helium detection technology and other intellectual property to provide services to those who explore for natural hydrogen and helium. The delivery of its first full function drone is expected in December 2021. This technology is a pivotal part of the Foothills hydrogen exploration program targeting identified areas of interest in North and South America. Natural hydrogen exploration has the potential to deliver the most inexpensive, reliable carbon-free hydrogen to power the hydrogen economy. The field of natural hydrogen exploration has recently emerged on the international stage as a potentially viable alternative production method with costs projected to be significantly lower than steam methane reforming and electrolysis using renewable energy. Natural hydrogen is clean and carbon-free with production costs estimated to be about $0.75 per kilogram, which is about 1/8th the current cost of producing green hydrogen.

08:13 EST Addus announces 'value-based' deal With Blue Cross/Blue Shield of New Mexico - Addus HomeCare announced it has entered into a "Stay Healthy at Home" value-based agreement with Blue Cross and Blue Shield of New Mexico, BCBSNM, for Medicaid members served by its subsidiary company, Ambercare Corporation . Ambercare is an operator of home health, hospice and personal care services in the State of New Mexico. The "Stay Healthy at Home" program is designed to help BCBSNM members obtain appropriate and timely care when a care gap or potential disease acceleration is identified by the client and/or their Addus caregiver. With that information, the Addus team will work with BCBSNM care coordination staff to remove barriers to service, coordinate with the member's primary care physician , and, when appropriate, mobilize community-based clinical care as an alternative to emergency room visits or hospital admissions. Service metrics and clinical quality outcome measures are key features of the program. The program will also include specific training for Addus' home care aides so they can more effectively identify and report changes in a member's condition that could require urgent intervention. These reports will be reviewed and coordinated by Addus care transition coordinators and communicated to the health plan and member's PCP for follow up. Addus will also assist with coordination and scheduling of medical procedures needed by members to close known Healthcare Effectiveness Data and Information Set care gaps.

08:12 EST Walmart CEO: Fighting inflation 'in our DNA'

08:11 EST Ballantyne announces confidential submission of draft registration statement - Ballantyne Strong announced that the Company has confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission relating to a proposed initial public offering of common shares of Strong Global Entertainment. The number of shares and price range for the proposed offering have yet to be determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.

08:10 EST Lightning eMotors to supply RideCo with zero-emission passenger vans for LA - Lightning eMotors announced an agreement with on-demand transit industry leader RideCo to provide zero-emission passenger vans for the Los Angeles County Metropolitan Transportation Authority . Under the agreement, Lightning eMotors will serve as the preferred zero-emission vehicle vendor for RideCo as it manages a fleet of vehicles for Metro Micro, a pilot program designed to provide fast and convenient rides within the service zones in Los Angeles County. Lightning eMotors will initially supply RideCo with 10 all-electric passenger vans. Several of those vehicles have already been delivered, and RideCo anticipates that all 10 will be transporting passengers around Los Angeles County by early next year. "From the outset, our goal was to introduce zero-emission vehicles into our fleet. After evaluating several potential vendors, Lightning eMotors emerged as a clear choice," said RideCo CEO Prem Gururajan. "We are excited to work with Lightning eMotors to deliver this innovative microtransit service in Los Angeles County."

08:10 EST R1 RCM selected by Adventist Health as patient billing partner - R1 RCM announced a new patient billing partnership with California-based Adventist Health. VisitPay, recently acquired by R1, provides the financial engagement component of Entri, R1's intelligent patient access platform. Through this partnership, Adventist Health will be able to utilize Entri's patient intake, registration and billing technology.

08:08 EST AutoNation opens AutoNation USA Phoenix Avondale - AutoNation announced the opening of AutoNation USA Phoenix Avondale, its second pre-owned vehicle store in the Phoenix market and the fourth new AutoNation USA store to open in 2021. With currently nine AutoNation USA stores in the nation, America's largest and most admired automotive retailer is on track to have more than 130 AutoNation USA stores in operation from coast to coast by the end of 2026, including plans for one more store in 2021 and 12 additional locations in 2022.

08:08 EST Frndly TV selects Magnite as ad server, primary SSP - Frndly TV announced that it has selected Magnite as its ad server and primary SSP in a bid to grow its ad-supported revenue streams. The announcement comes as the vMVPD continues to expand its offerings following consistent month over month growth.

08:06 EST U.S. Navy selects SAIC for $556M deal for support services for sailor HR - Science Applications International was awarded a contract to compete for task orders worth up to $556M supporting the Technical Services Support, TSS, 2 Contract for MyNavy HR Enterprise, part of the Navy's effort to modernize the way it delivers human resources service to sailors, their families and future recruits. The contract represents a continuation of SAIC's work on the Navy's previous TSS 1 contract. Under the five-year, indefinite-delivery/indefinite-quantity contract, SAIC will compete with other selected vendors to provide support services in 10 core function categories: CIO strategic support; data and information management; engineering support; IT system support; network support; information assurance/cybersecurity; enterprise business intelligence/enterprise business analytics; software analysis; hardware maintenance and development; and business process reengineering. "We are pleased that our track record of success on the first TSS contract made us a partner of choice for the U.S. Navy's follow-on program, and we are proud to be able to bring our innovation and transformative solutions to serve the Office of the Chief of Naval Operations and subordinate commands," said Bob Genter, president of SAIC's Defense and Civilian Sector. "We look forward to helping the Navy to modernize its human resources service delivery through SAIC's proven innovative enterprise IT engineering support and management." The Navy expects to complete work on this cost-plus-fixed-fee contract in October 2026 with an option to extend the ordering period to April 2027.

08:06 EST Applied Genetic appoints Abraham Scaria as CSO - Applied Genetic Technologies Corporation(AGTC) announced the appointment of Abraham Scaria, Ph.D., as Chief Science Officer. Most recently, Dr. Scaria was the Senior Vice President and Chief Science Officer at IVERIC Bio (ISEE), where he was responsible for preclinical research and development for retinal disease therapies.

08:05 EST DraftKings announces mobile sports betting deal with Boot Hill Casino & Resort - DraftKings (DKNG) announced a collaboration with BHCMC, a subsidiary of Butler National Corporation (BUKS), manager of Boot Hill Casino & Resort, to enter into a new market access deal, subject to sports betting legislation and regulations being adopted, and the receipt of all applicable licenses and approvals, that could bring the mobile Sportsbook to sports fans in the state of Kansas. "As we continue our quest to expand our mobile sportsbook footprint to every state in the U.S., we are eager to begin working with Boot Hill Casino & Resort," said Jeremy Elbaum, Senior Vice President Business Development, DraftKings. "We look forward to the opportunities that lay ahead and remain optimistic that Kansas lawmakers will enact common sense legislation that will benefit the state and its constituents."

08:04 EST ViaSat, Embraer collaborate on In-Flight Connectivity system - Viasat (VSAT) and Embraer (ERJ) announced they entered into a Buyer-Furnished Equipment agreement to offer Viasat's advanced In-Flight Connectivity system as a line-fit option on Embraer's family of E2 aircraft. Viasat is the first Ka-band IFC supplier to have a line-fit IFC solution available on the Embraer E2 family. By selecting Viasat's IFC system as a factory option on the Embraer E2 aircraft prior to delivery, airlines will be able to offer, from day one of aircraft service, an advanced IFC experience to each passenger and flight crew member, while avoiding costly down-time associated with taking aircraft out of service for post-production IFC retrofits. Multiple airlines, including Azul Airlines, have selected Embraer E2 aircraft equipped with Viasat's IFC system direct from the factory.

08:03 EST Walmart has seen a 'good start' to Q4, says CEO - Comments taken from Q3 earnings conference call.

08:02 EST Whirlpool to invest $65M into its factory in Ottawa - Whirlpool announced it is investing more than $65M over the next several years into its factory in Ottawa, Ohio as part of the company's ongoing efforts to position the plant as the Premium Refrigeration Factory in its North American Region, or NAR. The investment will include an expansion of the Ottawa plant to accommodate production of premium refrigeration products, including Built-In Refrigerator, or BIR, production. In addition to plant expansion, this investment will also create 100+ additional jobs. Expansion of the facility's existing footprint will begin in mid-2022, with Ottawa assuming full production in 2023.

07:55 EST Chatham submits binding offer to acquire R.R. Donnelley for $9.10 per share

07:43 EST NFI Group announces first battery-electric order from U-M for up to 54 buses - NFI Group announced that its subsidiary New Flyer of America has received an order from the University of Michigan-Transportation Services, U-M, for three zero-emission, battery-electric Xcelsior CHARGE NG forty-foot transit buses and one sixty-foot articulated Xcelsior CHARGE NG bus. The contract has a base term of one year with 13 one-year renewal terms, and marks New Flyer's first bus order from U-M. The contract also includes options for up to 50 Xcelsior heavy-duty transit buses in 35-foot, 40-foot and 60-foot lengths in both electric and diesel propulsion. "NFI is proud to support U-M's commitment to sustainability with our advanced battery-electric buses," said Chris Stoddart, President, North American Bus and Coach. "Drawing on over 50 years of engineering experience in zero-emission mobility, our EVs offer up to 250 miles in range on a single charge and will immediately reduce greenhouse gas emissions, delivering cleaner, quieter, more sustainable mobility to the U-M community."

07:41 EST Zai Lab announces first patient dosed in trial of efgartigimod in CIDP - Zai Lab announced that the first patient has been dosed in the Greater China portion of the global registrational ADHERE study of efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy, CIDP. The ADHERE trial is a registrational, prospective, multi-center study to investigate the safety and efficacy of weekly subcutaneous efgartigimod in adult patients with CIDP. The primary endpoint is event-driven and based on the adjusted Inflammatory Neuropathy Cause and Treatment, INCAT, overall disability score. "CIDP is a chronic and progressive disease characterized by progressive weakness and impaired sensory function in the legs and arms for which limited effective and well-tolerated treatment options exist," said Harald Reinhart, M.D., Chief Medical Officer, Autoimmune and Infectious Diseases at Zai Lab. "Due to the side effects of corticosteroids and limited access to intravenous immunoglobulin therapy in China, we are excited about the therapeutic potential of efgartigimod in CIDP and look forward to advancing the China portion of this registrational study."

07:38 EST Rio2 signs $50M gold stream with Wheaton Precious Metals on Fenix Gold Project - Rio2 Limited (RIOFF) is pleased to announce that it has entered into a definitive precious metals purchase agreement with Wheaton Precious Metals International (WPM), a wholly-owned subsidiary of Wheaton Precious Metals Corp., in relation to the Company's Fenix Gold Project in Chile. The Gold Stream is one of the components of the mine construction financing totaling approximately $125M to $135M to finance the construction of a mine at the Company's 100%-owned Fenix Gold Project in Chile. The signing of the Gold Stream agreement follows the successful completion in August 2021 of the Company's C$35.1M equity offering and positions the Company to finalize the previously announced $50M to $60M senior debt project finance facility with BNP Paribas mandated as sole lead arranger. Under the Gold Stream, Wheaton International will purchase 6.0% of the gold production from the Fenix Gold Project until 90,000 ounces of gold have been delivered and 4.0% of the gold production until 140,000 ounces of gold have been delivered, after which the stream will reduce to 3.5% of the gold production for the life of mine. Wheaton International will make an upfront deposit in cash of $50M with $25M available following closing of the Gold Stream agreement, and the remaining $25M payable after the receipt of the EIA approval for the Mine with both payments subject to completion of customary conditions. In addition, Wheaton International will make ongoing payments for gold ounces delivered equal to 18% of the spot gold price until the value of gold delivered less the production payment is equal to the upfront consideration of $50M, at which point the production payment will increase to 22% of the spot gold price.

07:38 EST Humacyte presents preclinical results from study of small-diameter HAV - Humacyte announced "positive" results from a preclinical study of the small-diameter HAV in a primate model simulating pediatric heart disease were presented at the American Heart Association's, AHA, Scientific Sessions 2021. In this initial preclinical study, five non-immunosuppressed juvenile primates were surgically implanted with the 3.5mm diameter HAVs as modified Blalock-Taussig-Thomas shunts, mBTTs. The mBTT shunt operation is used as an initial stage of some pediatric surgical procedures to repair severe congenital heart defects. The 3.5mm HAVs were implanted into primates as mBTT shunts using standard surgical techniques, and the animals were studied for three to six months. Each of the HAVs remained patent during the study and exhibited repopulation with vascular cells. The 3.5mm diameter HAV has smaller product dimensions but is manufactured using a similar process as Humacyte's 6mm HAV system currently being evaluated in advanced-stage clinical trials in vascular trauma, arteriovenous access for hemodialysis, and peripheral arterial disease. "Exploring the potential use of the HAV in cardiac surgical procedures represents a logical expansion of Humacyte's bioengineered vascular platform. Our HAVs are being tested in high-fidelity primate models of human heart disease, progressing our off-the-shelf regenerative medicine technology beyond the three vascular indications currently being evaluated in clinical trials," said Laura Niklason, M.D., Ph.D., Founder, President and Chief Executive Officer of Humacyte. "We have observed that HAVs repopulate with the patient's own cells to become living vascular tissues. This data demonstrates the potential of the small diameter HAV to remodel and regenerate in a similar way to become a living cardiovascular tissue, expanding the possibilities of the HAV platform, and potentially providing small diameter HAVs in the future as off-the-shelf options to improve outcomes in cardiac bypass surgery."

07:36 EST MoneyLion buys creator network and content platform MALKA Media, no terms - MoneyLion announced that it has acquired MALKA Media Group. The acquisition accelerates MoneyLion's ability to engage with consumers across all digital and emerging channels, allowing MoneyLion to directly connect with communities natively inside and outside of its platform. "This transaction is the evolution of a successful four-year partnership between MALKA and MoneyLion. We have seen first-hand how MALKA's content capabilities can drive industry-leading customer acquisition and retention at scale. By combining their capabilities with MoneyLion's financial products and extensive first party data, we will create a durable advantage that accelerates MoneyLion's customer growth and helps us serve our mission of providing financial access and advice to hardworking Americans," said Dee Choubey, Co-Founder and CEO of MoneyLion. "We will expand our vision of a daily destination, which started with our own MoneyLife content, with personalized content that educates, informs, and supports consumers' financial decision making. Through this acquisition, which we anticipate will be accretive and cash flow positive in 2022, we will now be able to fully leverage MALKA's capabilities so that the MoneyLion brand can truly live wherever our customers are investing their attention," continued Mr. Choubey

07:35 EST Quipt Home Medical executes LOI to acquire respiratory care company - Quipt Home Medical announces it has executed a non-binding letter of intent, LOI, to acquire an arm's length private respiratory care company in the Midwestern United States reporting unaudited trailing 12-month annual revenues of approximately $13M, $1.6Min net income, and positive Adjusted EBITDA. The target has a heavily weighted respiratory product mix, serving as a leader in the respiratory home care services space for over 25 years in a major metropolitan hub within a Midwestern U.S. state. The target would be expected to increase Quipt's active patient count by over 15,000, which would bring Quipt's total to approximately 170,000 active patients. According to the LOI, Quipt expects to close the acquisition for cash at a reasonable multiple that would immediately be accretive to Quipt's Adjusted EBITDA and net income. As part of the proposed acquisition the Company would not assume any long term debt of the target. Closing of the acquisition is subject to final due diligence, final negotiation and execution of a definitive purchase agreement, all closing conditions being satisfied or waived and all necessary approvals and is expected to occur within the next 60 days. "This is an extremely exciting growth period for Quipt as we see continued acceleration within the existing business and a plethora of strategic acquisition opportunities that we hope will help us scale into attractive markets across the United States," said Greg Crawford, Chairman and CEO of Quipt. "This acquisition target is very powerful as it services a significant metro hub in the Midwest and after closing, we plan on quickly integrating their business operations and leveraging the Company's payor contracts across our existing Midwest locations. We anticipate that this acquisition would be immediately accretive to Quipt's Adjusted EBITDA, overall profitability and would add approximately $13 million to the top-line and $1.6 million in net income. Additionally, we expect to see cross-selling growth from lathering on our clinical ventilation therapy program as an extension to their existing respiratory product mix. We expect to remain very active as we close out 2021 and enter 2022 and look forward to sharing our progress."

07:35 EST Canacol Energy announces pricing of $500M private offering of senior notes - Canacol Energy is pleased to announce the pricing and terms of its offering of senior unsecured notes in the aggregate principal amount of $500M. The 2028 Notes will pay interest semi-annually at a rate of 5.75% per annum, and will mature in 2028, unless earlier redeemed or repurchased in accordance with their terms. The 2028 Notes will be fully and unconditionally guaranteed by certain subsidiaries of Canacol. The settlement and closing of the 2028 Notes offering is expected to take place on November 24, 2021, subject to customary closing conditions. The 2028 Notes will be offered in a private placement to qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended, to non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act and pursuant to certain prospectus exemptions in Canada. Canacol intends to primarily use the net proceeds of the Offering to refinance its outstanding 7.250% Senior Notes due 2025 pursuant to the Tender Offer and Consent Solicitation described in Canacol's press release dated November 8, 2021, pay the fees and expenses of the Offering and the Tender Offer, to refinance certain other existing indebtedness of Canacol, and for general corporate purposes, including capital expenditures.

07:33 EST Cazoo acquires Swipcar for EUR 30M - Cazoo announced that it has acquired Swipcar, Spain's consumer car subscription marketplace. Founded in 2018, Swipcar has grown to a team of around 100 staff based in Barcelona and offers a selection of cars available from various leasing company partners for a single monthly subscription payment which includes the car, insurance, maintenance, service and tax. As well as operating in Spain, Swipcar has also recently launched in Italy and Portugal. The transaction will combine Cazoo's brand and platform with Swipcar's expertise and relationships in southern Europe and, once integrated, will accelerate the launch of Cazoo's full proposition into these markets. Cazoo acquired Swipcar for EUR 30M for a mix of cash & Cazoo shares and the transaction is expected to have a negligible impact on Cazoo's FY21 operating results.

07:32 EST OneWater Marine reaches agreement to acquire Norfolk Marine - OneWater Marine announced that it has reached an agreement to acquire Norfolk Marine, which will expand the company's presence in the Mid-Atlantic U.S. and enhance new and pre-owned boat sales, finance, and parts and services offerings. The transaction is expected to close in the fourth quarter of calendar 2021. "The OneWater family welcomes Jason Murphy and the Norfolk Marine team as we continue to execute on our growth strategy. This acquisition will add to our growing presence in the Mid-Atlantic region and will mark our first dealer in Virginia," said Austin Singleton, Chief Executive Officer for OneWater. "Jason and his team have contributed to the rich history of Norfolk Marine, and we look forward to providing support as they continue to expand their offerings."

07:29 EST Moderna says EU and EEA donate 70M doses of vaccine to COVAX in 2021 - Moderna announced an agreement that enables the European Union and European Economic Area countries to donate doses of the Moderna COVID-19 vaccine that they have purchased under the EU Vaccines Strategy to COVAX on an ongoing basis for delivery in 2021. This initiative, led by France, Sweden, and Norway is expected to enable the donation of more than 70 million doses of Moderna vaccine in 2021, including an initial donation of 15 million doses by France and 40 million doses by Germany. This agreement provides that donations of Moderna vaccine by EU and EEA countries to COVAX will be directed to the 92 Gavi COVAX Advance Market Commitment low- and middle-income countries. COVAX is a global initiative co-led by Gavi, the Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations and the World Health Organization , to ensure equitable access to COVID-19 vaccines for all countries, regardless of income levels. "I would like to thank the governments of France, Sweden and Norway, the EU and EEA countries and Gavi for this agreement to facilitate the donation of doses of the Moderna COVID-19 vaccine from the EU Member States to COVAX to help end the pandemic in low-income countries," said Stephane Bancel, Chief Executive Officer of Moderna. "We believe that dose sharing, among other strategies, will help ensure an equitable global distribution of COVID-19 vaccines. We remain focused on implementing a comprehensive and always evolving strategy to ensure that low-income countries get access to our vaccine as we seek to help end the pandemic around the world." Dose sharing is an important pillar of Moderna's comprehensive plan to bring vaccines to as many people as possible around the world. On October 21, Stephane Bancel published a letter on the path forward for global vaccination. On October 8, Stephane Bancel published a letter on Moderna's commitment to global vaccine access.

07:27 EST Calibre Mining provides update on company's drilling program - Calibre Mining provides an update of the Company's 2021 drilling program, highlighting recent results of exploration drilling and the discovery of a zone of high-grade gold mineralization along the Volcan trend located within five kilometres of the Libertad mill. Highlights: Confirmed good continuity of gold mineralization over a 1.5 kilometre strike length to a depth ranging from 100 to 250 metres with the vein system remaining open along strike and at depth; Eight of nine holes intercepted at least one vein structure hosting significant gold grades over estimated true widths ranging from 1.5 to 10 metres; A central zone of significantly higher-grade mineralization extends at depth between 150 and 250 metres from surface; To date, drilling has only tested a 1.5 kilometre section of the five kilometre Volcan trend which is located within 5 kilometres of the Libertad mill. Volcan Deposit Drill Results: 15.6 g/t gold over 4.9 metres Estimated True Width, ETW, from 96 metres and 7.88 g/t gold over 3.4 metres ETW from 116 metres; 3.91 g/t gold over 1.4 metres ETW from 100 metres and 4.13 g/t gold over 9.2 metres ETW from 122 metres; 8.75 g/t gold over 1.8 metres ETW from 165 metres and 3.80 g/t gold over 1.8 metres ETW from 214 metre. Darren Hall, President & Chief Executive Officer of Calibre, stated: "We are excited to report these latest drill results from our exploration program at Libertad confirming a second zone of high-grade gold mineralization along the prospective Volcan trend. In addition to delineating a 1.5-kilometre trend of near-surface gold mineralization, the discovery of a high-grade core zone which remains open at depth presents an opportunity to deliver another source of low-cost, high-margin mill feed within close proximity to the Libertad mill. Together with the delineation and resource conversion campaigns at the nearby Tranca and Rosario deposits, we continue to see excellent potential to leverage the plus one million tonnes of excess processing capacity at Libertad."

07:25 EST Clearside Biomedical announces presentations of XIPERE at AAO 2021 - Clearside Biomedical announced that multiple presentations were given at the American Academy of Ophthalmology, AAO, 2021, which took place November 12 - 15, 2021 in New Orleans, LA. Clearside AAO Presentations: Title: OCT Anatomic & Temporal Biomarkers in Uveitic Macular Edema. Conclusions: In clinical practice, physicians often base treatment decisions on best corrected visual acuity and/or optical coherence tomography assessment. This study assessed these relationships, focusing on baseline anatomic features with potential prognostic value for visual response. Importantly, this analysis showed that eyes with early anatomic response demonstrated better BCVA response at 24 weeks, and that anatomic response may precede visual response in UME by one month or more among patients treated with CLS-TA. Title: Post-Hoc Analysis of Suprachoroidal CLS-TA vs. Rescue Therapies in Macular Edema associated with Noninfectious Uveitis. Conclusions: In this post hoc analysis of the PEACTHREE trial, visual function and safety outcomes of unrescued CLS-TA subjects were compared to rescued subjects in the control group reflecting current clinical treatment. Unrescued CLS-TA subjects experienced statistically significant greater mean reduction in central subfield thickness versus controls. Unrescued CLS-TA subjects also trended towards greater mean improvement in BCVA with approximately 52% of those subjects gaining greater than or equal to 15 letters BCVA at 24 weeks versus 37% of subjects in the rescued control group. Title: Uveitic Macular Edema: Visual Function and Ocular Anatomy by Severity of Vision Loss. Conclusions: This poster represented a post hoc analysis of the Phase 3 PEACHTREE and AZALEA clinical trial patients who received triamcinolone acetonide injectable suspension for suprachoroidal use. There were BCVA and anatomic benefits observed in patients who received SCS-TA at 24 weeks regardless of baseline BCVA status. Clearside American Uveitis Society Presentations: Title: Suprachoroidal SCS-TA Safety and Efficacy in Macular Edema Associated with Uveitis: Post Hoc Analysis of Clinically Relevant Subgroups. Conclusions: These post hoc analyses results corroborate the prospectively planned analyses for PEACHTREE. When unrescued SCS-TA patients are compared to rescued control patients, the analysis showed a significantly greater reduction in CST, a trend towards greater BCVA improvement, and a lower incidence of intraocular pressure elevation and cataract. The benefit of SCS-TA was noted regardless of administration of systemic corticosteroid or steroid-sparing therapy at baseline versus the control patients. Title: Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal Imaging. Conclusions: This presentation compared suprachoroidal and intravitreal injections using several multimodal imaging diagnostics to demonstrate the injection flow differences between the two procedures. In summary, these multimodal imaging methodologies support the potential of suprachoroidal injections to target affected tissue layers in chorioretinal disorders.

07:20 EST Voyager Therapeutics to present preclinical data from vectorized program - Voyager Therapeutics announced it will present preclinical data from its vectorized antibody program at the 26th Society for Neuro-Oncology Annual Meeting on Nov. 19, 2021. SNO Oral Presentation Details: Title: "AAV mediated brain delivery of an ADCC-enhanced antibody obviates xenograft growth in mouse models of HER2+ breast cancer brain metastasis." Presenter: Dan R. Laks, Ph.D., Scientist II, Voyager Therapeutics

07:17 EST Lithia & Driveway opens two Audi stores in South Florida - Lithia & Driveway announced their entrance into South Florida with the addition of Audi Fort Lauderdale and Audi Coral Springs. The Florida stores dramatically increase LAD's luxury footprint in the Southeast Region and together are expected to generate $275M in annualized revenue. The addition of Audi Fort Lauderdale and Audi Coral Springs brings LAD's total expected annualized revenue acquired in 2021 to $6.5B. The company is pacing to exceed its 5-year plan, announced in July 2020, to reach $50B in revenue and $50 of EPS. These acquisitions were financed using existing on-balance sheet capacity.

07:16 EST TransDigm not providing FY22 guidance due to COVID-19 - The company said, "Given the considerable uncertainty around the extent and duration of business disruptions related to the COVID-19 pandemic and its impact on our primary commercial OEM and commercial aftermarket end markets, the Company will not provide full fiscal year 2022 guidance at this time. Information regarding fiscal 2022 EBITDA As Defined margins, expected defense market revenue growth, tax rates, interest expense, capital expenditures and select accounting information is included in the slide presentation available for today's earnings call."

07:13 EST Amarin to present latest clinical research evaluating VASCEPA/VAZKEPA - Amarin reported an overview of new data relating to VASCEPA(R)/VAZKEPA presented at the American Heart Association Scientific Sessions 2021, which took place virtually from November 13-15, 2021. Key data presented at AHA 2021: "Benefits of Icosapent Ethyl in Patients with Prior Peripheral Artery Disease: REDUCE-IT PAD." Highlights: The investigators concluded that, "Icosapent ethyl 4 g/day significantly reduced total primary endpoints by 32%, and trended toward a 22% reduction in first events, in patients with PAD. Icosapent ethyl provides substantial cardiovascular risk reduction in the high-risk REDUCE-IT population, with consistent benefits in patients with a history of PAD. Safety was generally consistent with the overall study." "Eicosapentaenoic Acid Restores Pulmonary Endothelial Nitric Oxide Bioavailability Following Exposure to Urban Air Pollution Small Particle." Highlights: This study examined the effects of EPA on pulmonary endothelial cell function and inflammatory state when challenged with air pollution particulate matter isolated from an urban environment. The study authors concluded that, "EPA significantly improved pulmonary endothelial cell function under conditions of inflammation caused by air pollution particles, including reductions in nitroxidative stress and the soluble adhesion molecule ICAM-1. These effects of EPA in pulmonary tissue challenged with air particulate matter indicate a novel potential benefit for further exploration in people exposed to air pollution." "Icosapent Ethyl Versus Placebo In Outpatients With COVID-19: The Main Results Of PREPARE-IT 2." Highlights: This was an investigator-initiated trial to evaluate the efficacy of icosapent ethyl to reduce hospitalizations or death in approximately 2000 patients in Argentina with a positive diagnosis for the COVID-19 virus. In this study, subjects were randomized 1:1 to receive IPE or placebo and received a loading dose of 8g per day of IPE for the first three days followed by 4g per day of IPE thereafter from days 4-28. "While the results of the PREPARE-IT 2 study in Argentina did not meet the primary and/or other endpoints studied, we believe it is valuable for Amarin to support pilot IITs of this nature to determine the safety and potential efficacy of VASCEPA/VAZKEPA in a diverse group of at-risk populations. Importantly, the study supports the safety and tolerability of VASCEPA/VAZKEPA at varying doses," the company said.

07:11 EST SoundHound AI to become public through Archimedes Tech SPAC Partners merger - SoundHound and Archimedes Tech SPAC Partners (ATSPU), a blank check company, announced they have entered into a definitive merger agreement. The combined company will be called SoundHound AI and is expected to be publicly listed on Nasdaq under the symbol (SOUN) following the closing of the transaction. SoundHound's technology has been developed over the last 16 years and includes 227 patents granted or pending with solutions available across cloud-only, embedded-only, and hybrid connectivity. The technology is available in 22 languages, with additional languages planned in the near future. The company's developer platform, Houndify, gives clients access to dashboards and development tools to analyze customer usage. Following completion of the transaction, SoundHound will retain its management team, which includes Keyvan Mohajer founder and CEO. The transaction is expected to deliver up to $244M of gross proceeds, including the contribution of up to $133M of cash held in Archimedes' trust account, subject to redemptions by Archimedes subunit holders. Of such amount, $111M will come from fully-committed common equity PIPE that is priced at $10.00 per share. All cash remaining on Archimedes' balance sheet at the closing of the transaction, after paying off transaction expenses, is expected to remain on SoundHound AI's balance sheet for working capital, growth capex, and other general corporate purposes. The board of directors of SoundHound and Archimedes, respectively, have approved the transaction. The transaction will require the approval of the stockholders of Archimedes and SoundHound, and is subject to other customary closing conditions, including the receipt of certain regulatory approvals. The transaction is expected to close in Q1 of 2022. As part of the transaction, the outstanding equity of SoundHound will be converted into equity of the combined company.

07:09 EST PolyPid appoints Frederick Lang to Oncology Advisory Board - PolyPid announced the appointment of Frederick Lang, M.D., to its Oncology Advisory Board. Lang is chairman of Neurosurgery at The University of Texas MD Anderson Cancer Center, a position he has held since 2018, and is co-leading MD Anderson's Glioblastoma Moon Shot initiative, which is dedicated to saving the lives of patients through the development of new therapies and better treatment approaches. In September 2021, PolyPid announced positive preclinical data for its intra-tumoral OncoPLEX in animal models of Glioblastoma Multiform. The Company is scheduled to conduct a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration later this month to potentially initiate a Phase 1/2 clinical trial in 2022. Dr. Lang receives compensation as a member of the Oncology Advisory Board, and this financial relationship has been disclosed to MD Anderson's Conflict of Interest Committee in accordance with institutional policy.

07:07 EST Pico announces introduction of new client portal - Pico announced the introduction of a new client portal to support more efficient and effective client-centric service delivery, at scale. The company said, "The portal empowers clients with on-demand access to a single, secure, centralized location to interact with their Pico services. Value highlights delivered to clients via the portal include: Visibility and intelligence into the current and historical performance of Pico's infrastructure and resilient proprietary network PicoNet, via instrumentation and telemetry metrics gathered by Pico's market leading Corvil Analytics; Tailored reporting with daily, weekly, monthly and historical reporting on venue access network bandwidth utilization and WAN latency, providing insight to help achieve optimal performance; Operational efficiencies through an optimized, self-service desk that streamlines the process of logging and tracking tickets, requesting additional services, as well as engaging directly with regional data center on-site staff; Situational awareness via alerts on the operational state of Pico services, infrastructure, and connectivity as well as notifications to view and approve Pico managed changes; Ease-of-use through a comprehensive dashboard, tools for ad-hoc file sharing between client and Pico teams, as well as the ability to manage user access and privileges." On August 4, 2021, Pico announced that it had entered into a definitive agreement for a business combination with FTAC Athena Acquisition Corp., a special purpose acquisition company. Upon closing of the transaction, the combined company will operate as Pico. The transaction reflects a pro forma enterprise value for the combined company of approximately $1.4B. The business combination, which has been unanimously approved by the boards of directors of both Pico and FTAC Athena, is targeted to close in early 2022, subject to stockholder approvals and other customary closing conditions.

07:05 EST Aurora Cannabis names new genetics licensing business unit as Occo - Aurora Cannabis announced the naming of the Company's new genetics licensing business unit - Occo - a leading innovator in the scientific discovery and commercial advancement of novel cannabis cultivars, backed by Aurora's state-of-the-art breeding and genetics facility in Comox, British Columbia. Occo will be based out of Aurora's Coast research and development hub. The team includes experts in genomics, biotechnology, pathology, tissue culture, analytics and testing, medical affairs, and product development. New to the team is Casey Whelan, Vice President of Genetics Business Development, who will lead Occo's efforts to license genetics to LPs in Canada and around the world. A lawyer by training, Casey joins Occo after spending a decade in breeding and licensing premium agricultural products.

07:05 EST Penske Automotive acquires McCoy Freightliner, terms unidsclosed - Penske Automotive announced that it has acquired McCoy Freightliner, a retailer of medium and heavy-duty commercial trucks, located in Oregon. The McCoy acquisition is expected to generate approximately $200M in annualized revenue, building further scale within the Company's wholly-owned Premier Truck Group subsidiary. McCoy adds two full-service dealerships and a remarketing center to Premier Truck Group's existing operations. PTG now operates thirty-seven North American commercial truck locations in Texas, Oklahoma, Oregon, Tennessee, Georgia, Utah, Idaho and Ontario, Canada, which the company expects to generate $2.5B in annual revenue. Year-to-date, Penske Automotive Group has added approximately $1.1B in expected annualized revenue through the completion of retail automotive and commercial truck dealerships.

07:04 EST ADMA Biologics commences operations at new ADMA BioCenters location - ADMA Biologics announced the commencement of operations and initiation of donor plasma collections at its newest ADMA BioCenters location in Myrtle Beach, South Carolina. ADMA BioCenters' collection center located in Myrtle Beach, South Carolina features automated registration, Haemonetics' Persona plasma collection solution for the NexSys PCS system designed to shorten the donation process and increase collection yields, free Wi-Fi wireless network in the donor collection area, individual flat-screen TVs with cable at each donor station, and highly trained and certified staff who put donor comfort and safety first. At full capacity, the center expects to maintain a staff of up to 50 highly trained healthcare workers. Pursuant to updated FDA direction to obtain approval for plasma collection centers, sponsors are now required to collect plasma donations for three months prior to submitting a Biologics License Application filing. Accordingly, ADMA expects to file its BLA for the Myrtle Beach, South Carolina plasma collection facility in approximately three months and anticipates a standard 12-month BLA review period by the FDA. In the meantime, ADMA is permitted to collect plasma donations at this site and, once the site is FDA approved, ADMA can utilize the plasma collected for further use in the manufacturing of life saving therapies.

07:03 EST Gogo's AVANCE L5 has flown on more than 500,000 flights - Gogo Business Aviation's AVANCE L5 has flown on more than 500,000 flights since it launched in August of 2017. There are currently more than 1,500 aircraft flying with an AVANCE L5 system onboard, and across the half a million flights that have been flown with L5, 273.7 terabytes of data have been consumed. Across Gogo's systems, flight counts on Gogo-equipped aircraft continue to grow, with Q3 flight counts up 24% compared to the pre-Covid Q3 of 2019. Also in the Q3, Gogo saw a 78% increase in megabytes consumed per day on its network and a 44% increase in megabytes per flight as compared to the Q3 of 2019.

06:50 EST XP Inc. acquires minority stake in Vista Capital - XP Inc. announced the acquisition of a minority stake in Vista Capital, one of the main independent equity and hedge funds managers in Brazil, with over R$4.5B in Assets Under Management. This transaction reinforces XP's strategy to develop the most complete ecosystem of managers and distributors in Brazil.

06:47 EST Ocean Power acquires Marine Advanced Robotics for $11M - Ocean Power Technologies announced the Company closed on an acquisition of Marine Advanced Robotics a Richmond, San Francisco Bay Area, California-based developer and manufacturer of autonomous surface vehicles, or ASVs. MAR is the developer of Wave Adaptive Modular Vessel, or WAM-V, technology, which enables roaming capabilities for uncrewed equipment in waters around the world. Terms of the Deal are: $11.0M paid at closing, consisting of $4.0M in cash and $7.0M in OPT common stock; additional earn-out opportunity for MAR based on revenue performance over the next two years; the MAR management team and employees have joined OPT. Marine Advanced Robotics continues to operate under its current brand name as a wholly owned subsidiary of OPT.

06:34 EST ImmunoGen names Kristen Harrington-Smith as Chief Commercial Officer - ImmunoGen (IMGN) announced that Kristen Harrington-Smith has been appointed Senior Vice President and Chief Commercial Officer. Harrington-Smith joins ImmunoGen from Novartis (NVS), where she served as US Commercial Head of Hematology and led the teams responsible for a broad portfolio of therapies in both benign and malignant hematologic diseases.

06:20 EST Impossible Foods debuts Impossible Meatballs at Walmart - California-based Impossible Foods is debuting Impossible Meatballs Made From Plants, the company's third new retail product in four months, as it continues to expand its presence on grocery store shelves. Available at Walmart (WMT) stores starting this month and coming to additional retailers later this year, the new Impossible Meatballs mark an expansion of Impossible Foods' presence at Walmart, which is launching a dedicated plant-based destination in its frozen aisle that will include Impossible products at more than 3,000 locations, the company said in a statement. Plant-based meat producer Impossible Foods competes with Beyond Meat (BYND).

06:05 EST NewAge files patent on new anti-aging discovery - NewAge announced the discovery of a new method of action to fight the effects of aging and the filing of a new patent to protect the uniqueness of the discovery. Following publication in the Journal of Biosciences and Medicine of the recent discovery on how to block spike proteins from binding to human cells, NewAge scientists have filed for a patent that contains multiple unique claims, and a new discovery that supports cardiovascular health and anti-aging. The new discovery encapsulated in the patent includes a powerful new way to unblock the secretion signal from the hypothalamus, thereby stimulating the anterior pituitary gland to naturally secrete human growth hormone.One of the major contributors to aging and the decline in cardiovascular health is the increase in the production of dipeptidyl-peptidase 4. DPP4 acts a signal to the anterior pituitary and it degrades over time as humans biologically age. With a new combination of natural ingredients including Tahitian NONI fruit and pterostilbene, NewAge scientists have developed a method of action to unblock the DPP4 signal by 99.1% and allow the secretion from the hypothalamus to the anterior pituitary, thereby triggering the body to naturally regulate itself and secrete growth hormone, as it did when the body was in growth and development mode versus in the aging process.

06:05 EST EV Connect selected by General Motors as an EV Charging solutions provider - EV Connect announced that the company is one of the approved EV Charging solutions providers to support the deployment of charging at General Motors' across the U.S and Canada. As an approved platform to support GM's EV dealerships, EV Connect will offer its EV charging management solutions that include advanced data analytics and 24/7 customer support. The first charging stations under the new program have been installed at select GM dealers, with more installations occurring this year. Through EV Connect's open charging cloud platform, GM dealerships will have the ability to optimize charging solutions at their stores to meet individual dealership needs. EV Connect will also provide comprehensive training for the software management platform for all participating dealerships to ensure a simple, reliable, and manageable charging experience.

05:44 EST Triumph Group awarded two-year contract with Calidus Aerospace - Triumph Group announced that its Triumph Mechanical Solutions facility in Heiligenhaus, Germany has been awarded a two-year contract with Calidus Aerospace to design, develop and manufacture the throttle quadrant assembly for the B-250 aircraft. Triumph developed a complete sub-system solution for Calidus, comprising the engine control, quadrant, and linkages in a single and fully integrated solution. This is Triumph's first award with Calidus, the United Arab Emirates-based manufacturer of the B-250 aircraft. The B-250 is a superior and highly efficient light attack aircraft that is designed specifically for asymmetric warfare zones and easily adapts to the most difficult terrain and weather conditions.

05:35 EST Boeing receives order for four airplanes from United Republic of Tanzania - Boeing and the United Republic of Tanzania announced an order for a 787-8 Dreamliner, a 767-300 Freighter and two 737 MAX jets at the 2021 Dubai Airshow. The airplanes will be operated by Air Tanzania, the national flag-carrier of Tanzania, to expand service from the country to new markets across Africa, Asia and Europe. The order, valued at more than $726M at list prices, was previously unidentified on the Boeing Orders and Deliveries website.

05:28 EST Autoliv announces new $1.5B share repurchase program - The Autoliv board of directors has approved a new stock repurchase program that authorizes the company to repurchase up to $1.5B or up to 17M common shares, between January 2022 and the end of 2024. This new stock repurchase program will replace the current program, which had approximately 3M shares remaining. Under the new repurchase program, Autoliv management can initiate repurchases opportunistically at their discretion, subject to applicable legal requirements. Autoliv will provide additional information relating to the new stock repurchase program towards the end of the year.

05:15 EST Rio Tinto announces investment in Inobat - Rio Tinto is supporting the development of a battery ecosystem in Europe with an investment in Inobat Auto, a European-based battery technology and manufacturing company. This investment will support the completion of InoBat's research and development center and pilot battery line in Voderady, Slovakia. The investment follows a memorandum of understanding signed in May, outlining an intention to work together to progress the establishment of a "cradle-to-cradle" electric vehicle battery value chain in Serbia. InoBat is actively pursuing plans to build a number of gigafactories, including one in Serbia. The company specializes in the pioneering research, development, manufacture, and provision of electric batteries custom-designed to meet the specific requirements of customers within the automotive, commercial vehicle, motorsport and aerospace sectors.

05:10 EST Allot Ltd. selected by Field Solutions Group to provide cybersecurity services - Allot Ltd. announced that Field Solutions Group, Australia's rural, regional, and remote challenger telecommunications carrier, has selected Allot Secure to protect the company's fixed broadband consumer and small and medium business customers against a broad range of cyber threats. "With network-based cybersecurity services, Field Solutions Group will have a zero-touch solution that makes customer onboarding easy," said Daniel Keidar, Head of Sales, Oceania for Allot. "The Allot cybersecurity solution will help Field Solutions Group to protect their customers while generating new revenue."